Not Signed In -
Diclofenac |
Voltaren |
Clinical Trial: A Study to Assess Etoricoxib Versus Diclofenac in Chinese Patients with Osteoarthritis of the Knee or Hip
This study is no longer recruiting patients.
|
Purpose
A Study to Assess Etoricoxib versus Diclofenac in Chinese Patients with Osteoarthritis of the Knee or Hip
| Condition | Intervention | Phase |
|---|---|---|
| Osetoarthritis | Drug: MK0633; etoricoxib | Phase IV |
MedlinePlus consumer health information
Study Type: Interventional
Study Design: Treatment, Randomized, Double-Blind, Active Control, Parallel Assignment, Safety/Efficacy Study
Official Title: A Multicenter, Randomized, Parallel-Group, 4-Week, Double-Blind and Active Comparator-Controlled Study to Assess Efficacy, Safety, and Tolerability of Etoricoxib 60 Mg Once Daily Versus Diclofenac Sodium 75 Mg Twice Daily in the Treatment of Chinese Patients with Osteoarthritis of the Knee or Hip
Further Study Details:
Study start: December 2004
Eligibility
Ages Eligible for Study: 40 Years and above, Genders Eligible for Study: Both
Criteria
Inclusion Criteria:
- Chinese males or females at least 40 years of age with osteoarthritis of the knee or hip
Location Information
China
Merck Sharp & Dohme (China) Ltd., Beijing, 100738, China
Study chairs or principal investigators
Medical Monitor, Study Director, Merck
More Information
Study ID Numbers: 2005_060
Last Updated: August 31, 2005
Record first received: August 30, 2005
ClinicalTrials.gov Identifier: NCT00140972
Health Authority: China: State Food and Drug Administration
ClinicalTrials.gov processed this record on 2005-09-13
Last Updated: August 31, 2005
Record first received: August 30, 2005
ClinicalTrials.gov Identifier: NCT00140972
Health Authority: China: State Food and Drug Administration
ClinicalTrials.gov processed this record on 2005-09-13
Resources
- Diclofenac (Drug Digest)
- Voltaren (Drug Digest)
email this page
print this page
bookmark this page
feedback on this page
